506 related articles for article (PubMed ID: 17257993)
1. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
4. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
5. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
6. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
7. Positive heparin-platelet factor 4 antibody complex and cardiac surgical outcomes.
Kress DC; Aronson S; McDonald ML; Malik MI; Divgi AB; Tector AJ; Downey FX; Anderson AJ; Stone M; Clancy C
Ann Thorac Surg; 2007 May; 83(5):1737-43. PubMed ID: 17462391
[TBL] [Abstract][Full Text] [Related]
8. Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery.
Bennett-Guerrero E; Slaughter TF; White WD; Welsby IJ; Greenberg CS; El-Moalem H; Ortel TL
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1567-72. PubMed ID: 16308000
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
10. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
[TBL] [Abstract][Full Text] [Related]
11. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
[TBL] [Abstract][Full Text] [Related]
13. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
[TBL] [Abstract][Full Text] [Related]
16. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
Levy JH; Tanaka KA; Hursting MJ
Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
18. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
20. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
